Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor*-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor*

Published:2020-01-28 Issue: Volume: Page:jpet.119.261065
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Moore Eric,Fraley Mark E.,Bell Ian M.,Burgey Christopher S.,White Rebecca B.,Li Chi-Chung,Regan Christopher P.,Danziger Andrew,Stranieri Michener Maria,Hostetler Eric,Banerjee Pradeep,Salvatore Christopher

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrocyclization strategy for improving candidate profiles in medicinal chemistry;European Journal of Medicinal Chemistry;2024-06

2. Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy;CNS Drugs;2024-05-31

3. A Review of Calcitonin Gene-Related Peptide and Its Implications for Vestibular Disorders;Current Treatment Options in Neurology;2024-05-23

4. Novel insight into atogepant mechanisms of action in migraine prevention;Brain;2024-02-27

5. Pharmacokinetics of Ubrogepant in Healthy Japanese and White Adults;Clinical Pharmacology in Drug Development;2024-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP